Jointly developed by investigators of the Vall d’Hebron Institute of Oncology’s (VHIO) Radiomics Group and the Bellvitge University Hospital’s Neuroradiology Unit, the Diagnosis in Susceptibility Contrast Enhancing Regions for Neuroncology (DISCERN) is an open-access deep learning tool based on the training of patterns using artificial intelligence models from information of standard magnetic resonance imaging (MRI).
Comments are closed.